Trial Profile
Phase II Trial of Docetaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2017
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Carboplatin
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 27 May 2017 Status changed from recruiting to completed.
- 02 Nov 2011 New trial record